2025年5月，总部位于美国马萨诸塞州的医疗科技公司Outcomes4Me获得了2100万美元的融资，本轮融资由Salica Investments领投，Labcorp Venture Fund和 Forecast Labs进行参投。 截止目前，Outcomes4Me总融资额达到3800万美元（约2.7亿元），这些资金将用来进一步开发其核心产品——AI驱动的癌症护理平台，为患者提供更加 个性化和智能化的解决方案，以改善癌症护理体验。 | 企业名称 | 融资时间 | 轮次 | 融资金额 | 主要投资方 | | --- | --- | --- | --- | --- | | Outcomes4Me | 2020年11月 | 种子轮 | 470万美元 | Asset Management Ventures | | | 2021年4月 | A轮 | 1200万美元 | Northpond Ventures | | | 2025年5月 | A轮+ | 2100万美元 | Salica Investments | （Outcomes4Me融资历程，动脉网制图） Maya R. Said博士是Outcomes4Me的创始人 ...

CITI'S TAKE Flash | 12 Jun 2025 04:35:43 ET │ 9 pages China Materials 2025 On-ground Demand Monitor Series #83 – Steel Inventory and Consumption Data In this series of notes, we aim to track and analyze high-frequency on- ground demand trends in China – market expectations of a demand recovery have been largely cautious. We have shifted our near-term pecking order to steel > aluminum > lithium > copper > gold > battery > thermal coal > cement names. We have opened CWs for Chalco (note) and Tianqi (note) and ...

本报记者 杨让晨 石英婧 上海报道 日前，"2025中国银发人居发展大会"在上海举行。受访者/图 据《2025中国银发人居发展报告》，随着中国老龄化进程加速，银发经济规模即将突破10万亿元大关， 而银发地产作为银发经济的核心支柱产业，从养老地产的单一养老功能转型，满足银发人群居住生活的 多元需求。 日前，以"让老年人住得更好"为主题的"2025中国银发人居发展大会"在上海举行。《中国经营报》记者 注意到，多位业内人士聚焦银发经济下老年人居住的核心议题，在社会关注"养老"的基础上，着重满足 银发人群"享老""乐老"等多元化需求，凝聚行业力量探索银发人居高质量发展路径。 易居（中国）控股有限公司董事局主席、中国房地产业协会康养分会会长周忻表示，银发人居是银发地 产的一部分，目的是让老年人住得更好，并且场景众多。 著名经济学家、上海财经大学校长刘元春表示，银发经济不仅是福利体系、社会主义现代化体系建设的 核心部分，也是当前改变消费率过低的结构性问题和解决消费不足的周期性问题的着眼点。"这能够通 过机制体制的设计，实现自我循环和发展，所以定位银发经济需要我们有更宽的视野，有更好的战略理 念。" 养老业态加速转变 不过 ...

Calko Medical Building Brooklyn, NY Earnings Release and Supplemental Report First Quarter 2025 ___________________________________________________________________ To learn more about Healthpeak's commitment to responsible business and view our most recent Corporate Impact Report, please visit www.healthpeak.com/corporate-impact. Return to TOC 3 – Net income of $0.06 per share, Nareit FFO of $0.45 per share, FFO as Adjusted of $0.46 per share, AFFO of $0.43 per share, and Total Same-Store Portfolio Cash (Ad ...

Core Viewpoint - Healthpeak Properties, Inc. reported first-quarter 2025 funds from operations (FFO) as adjusted per share of 46 cents, meeting expectations and showing a slight increase from 45 cents in the prior year, driven by better-than-anticipated revenues despite higher interest expenses [1][2]. Financial Performance - The company generated revenues of $702.9 million, exceeding the Zacks Consensus Estimate of $691.9 million, representing a year-over-year increase of 15.9% [2]. - Healthpeak reported a 7% year-over-year growth in total merger-combined same-store cash (adjusted) net operating income (NOI) [3]. - The outpatient medical and lab segments experienced year-over-year growth of 5% and 7.7%, respectively, while the Continuing Care Retirement Communities (CCRC) segment reported a growth of 15.9% [3]. Lease Activity - In the reported quarter, Healthpeak executed lab new and renewal leases totaling 276,000 square feet, achieving a retention rate of 88% and +5% cash-releasing spreads on renewals [4]. - For the outpatient medical portfolio, new and renewal leases totaled 973,000 square feet, with a retention rate of 86% and +4% cash-releasing spreads on renewals [4]. Balance Sheet - As of March 31, 2025, Healthpeak had cash and cash equivalents of $70.6 million, down from $119.8 million at the end of 2024, with a net debt to adjusted EBITDAre ratio of 5.2X [5]. - The company repurchased 5.1 million shares at a weighted average price of $18.50, totaling $94 million, from the beginning of the year through April 24 [5]. 2025 Outlook - Healthpeak reaffirmed its guidance for 2025, expecting FFO as adjusted per share to be between $1.81 and $1.87, with the Zacks Consensus Estimate at $1.85 [6]. - The company anticipates total merger-combined same-store cash (adjusted) NOI growth in the range of 3-4% for the year [6].